This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
The interim data combines three mRNAs into one therapy injected directly into the tumour
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
The preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVac’s first-generation mRNA backbone
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The backing comes as influenza remains a persistent public health burden
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
CEO Stéphane Bancel framed the changes as essential to scaling the business
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
